Hendrix MJ - Search Results

1

Differential role of tissue factor pathway inhibitors 1 and 2 in melanoma vasculogenic mimicry.

Ruf W, Seftor EA, Petrovan RJ, Weiss RM, Gruman LM, Margaryan NV, Seftor RE, Miyagi Y, Hendrix MJ. Ruf W, et al. Among authors: hendrix mj. Cancer Res. 2003 Sep 1;63(17):5381-9. Cancer Res. 2003. PMID: 14500372

2

Transendothelial function of human metastatic melanoma cells: role of the microenvironment in cell-fate determination.

Hendrix MJ, Seftor RE, Seftor EA, Gruman LM, Lee LM, Nickoloff BJ, Miele L, Sheriff DD, Schatteman GC. Hendrix MJ, et al. Cancer Res. 2002 Feb 1;62(3):665-8. Cancer Res. 2002. PMID: 11830517

3

Targeting the tumor microenvironment with chemically modified tetracyclines: inhibition of laminin 5 gamma2 chain promigratory fragments and vasculogenic mimicry.

Seftor RE, Seftor EA, Kirschmann DA, Hendrix MJ. Seftor RE, et al. Among authors: hendrix mj. Mol Cancer Ther. 2002 Nov;1(13):1173-9. Mol Cancer Ther. 2002. PMID: 12479698

4

Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma.

Hendrix MJ, Seftor EA, Hess AR, Seftor RE. Hendrix MJ, et al. Nat Rev Cancer. 2003 Jun;3(6):411-21. doi: 10.1038/nrc1092. Nat Rev Cancer. 2003. PMID: 12778131 Review.

5

Phosphoinositide 3-kinase regulates membrane Type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry.

Hess AR, Seftor EA, Seftor RE, Hendrix MJ. Hess AR, et al. Among authors: hendrix mj. Cancer Res. 2003 Aug 15;63(16):4757-62. Cancer Res. 2003. PMID: 12941789

6

Focal adhesion kinase promotes the aggressive melanoma phenotype.

Hess AR, Postovit LM, Margaryan NV, Seftor EA, Schneider GB, Seftor RE, Nickoloff BJ, Hendrix MJ. Hess AR, et al. Among authors: hendrix mj. Cancer Res. 2005 Nov 1;65(21):9851-60. doi: 10.1158/0008-5472.CAN-05-2172. Cancer Res. 2005. PMID: 16267008

7

VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: implications for vasculogenic mimicry.

Hess AR, Seftor EA, Gruman LM, Kinch MS, Seftor RE, Hendrix MJ. Hess AR, et al. Among authors: hendrix mj. Cancer Biol Ther. 2006 Feb;5(2):228-33. doi: 10.4161/cbt.5.2.2510. Epub 2006 Feb 14. Cancer Biol Ther. 2006. PMID: 16481735

8

Regulation of the embryonic morphogen Nodal by Notch4 facilitates manifestation of the aggressive melanoma phenotype.

Hardy KM, Kirschmann DA, Seftor EA, Margaryan NV, Postovit LM, Strizzi L, Hendrix MJ. Hardy KM, et al. Among authors: hendrix mj. Cancer Res. 2010 Dec 15;70(24):10340-50. doi: 10.1158/0008-5472.CAN-10-0705. Cancer Res. 2010. PMID: 21159651 Free PMC article.

9

Molecular pathways: vasculogenic mimicry in tumor cells: diagnostic and therapeutic implications.

Kirschmann DA, Seftor EA, Hardy KM, Seftor RE, Hendrix MJ. Kirschmann DA, et al. Among authors: hendrix mj. Clin Cancer Res. 2012 May 15;18(10):2726-32. doi: 10.1158/1078-0432.CCR-11-3237. Epub 2012 Apr 2. Clin Cancer Res. 2012. PMID: 22474319 Free PMC article.

10

Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2).

Hess AR, Seftor EA, Gardner LM, Carles-Kinch K, Schneider GB, Seftor RE, Kinch MS, Hendrix MJ. Hess AR, et al. Among authors: hendrix mj. Cancer Res. 2001 Apr 15;61(8):3250-5. Cancer Res. 2001. PMID: 11309274

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

285 results

Search Page